Latest Investment Funding News

FMR Resources has raised $3.4 million through a strategic equity placement to accelerate exploration at its Southern Porphyry target in Chile, aiming to unlock significant copper and gold potential.

AIMS Property Securities Fund (APW) reported a remarkable financial year ending June 2025, with net income and revenue more than doubling and net tangible assets per unit rising 31.8%. The fund’s conservative, debt-free approach and diversified portfolio helped it outperform the broader market despite ongoing distribution suspensions.

Acorn Capital Investment Fund Limited reported a robust FY25 with a $9.67 million profit after tax, a significant leap from $1.77 million the prior year, while delivering a 15.1% portfolio return that outperformed its benchmark.

Regal Investment Fund reported a sharp 78% drop in operating profit for FY25 but maintained steady performance slightly above the RBA Cash Rate. The fund bolstered its position with a $104 million capital raise and extended its on-market buy-back program through mid-2026.

Alternative Investment Trust (ASX, AIQ) reported a robust half-year profit increase of 183%, driven by strong gains in its Warana-managed portfolio. The Trust also announced a significant $44.6 million rights issue to fund further investments.

Future Generation Australia reports a notable drop in half-year profits for 2025 but announces an increased fully franked interim dividend, reflecting confidence in its long-term investment strategy and social impact commitments.

Omni Bridgeway Limited has reported a robust FY25 with full debt repayment, strong portfolio returns, and strategic capital raises positioning it as a leader in legal finance. The company’s disciplined cost management and validated fair value approach underpin its confident outlook for FY26.

Gryphon Capital Income Trust (ASX, GCI) reported a robust fiscal 2025 with a 41.65% jump in revenue and a substantial capital raise to expand its RMBS/ABS portfolio. The Trust’s net assets topped $1 billion, reflecting strong investor confidence and strategic growth.

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.

Katana Capital Limited reported a solid increase in net profit for FY2025 alongside a fully franked dividend and a strategic share buyback, signaling confidence despite lower revenue.

The Australian Wealth Advisors Group Ltd (AWAG) reported a 13% revenue increase and a $1.2 million profit before tax in FY2025, driven by strategic Equity Partnership Scheme investments and a strong funds under management base.

Papyrus Australia clarifies it has signed a binding term sheet, not a final agreement, with AQN for biodegradable boards, contingent on facility setup and product testing.